EGFR protein overexpression correlates with chromosome 7 polysomy and poor prognostic parameters in clear cell renal cell carcinoma
Open Access
- 5 April 2012
- journal article
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 19 (1) , 40
Abstract
Background: The role of epidermal growth factor (EGF) and its receptor (EGFR) in the pathogenesis and progression of various malignant tumors has long been known, but there is still disagreement concerning prognostic significance of EGFR expression in clear cell renal cell carcinoma (CCRCC). The present study was designed to analyze more objectively the protein EGFR expression in CCRCC and to compare its value with EGFR gene copy number changes and clinicopathologic characteristics including patient survival. Methods: The protein EGFR expression was analyzed immunohistochemically on 94 CCRCC, and gene copy number alterations of EGFR by FISH analysis on 41 CCRCC selected according to distinct membrane EGFR staining. Results: Membrane EGFR expression in tumor cells was heterogeneous with respect to the proportion of positive cells and staining intensity. FISH analysis did not reveal EGFR gene amplification, while polysomy of chromosome 7 found in 41% was associated with higher EGFR membrane expression. Moreover, EGFR overexpression was associated with a higher nuclear grade, larger tumor size and shorter patient's survival, while there was no connection with pathological stage. Conclusion: In conclusion, the protein expression of EGFR had an impact on prognosis in patients with CCRCC, while an increased copy number of chromosome 7 could be the possible reason for EGFR protein overexpression in the absence of gene amplification.Keywords
This publication has 30 references indexed in Scilit:
- Characterization of membranous and cytoplasmic EGFR expression in human normal renal cortex and renal cell carcinomaJournal of Biomedical Science, 2009
- The EGFR Protein Expression and the Gene Copy Number Changes in Renal Cell CarcinomasThe Korean Journal of Pathology, 2009
- An overview of the epidermal growth factor receptor fluorescence in situ hybridisation challenge in tumour pathologyJournal of Clinical Pathology, 2008
- EGFR FISH versus mutation: Different tests, different end-pointsLung Cancer, 2008
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerJournal of Clinical Oncology, 2007
- Epidermal growth factor receptor (EGFR) signaling in cancerGene, 2006
- Are heterogenous results of EGFR immunoreactivity in renal cell carcinoma related to non-standardised criteria for staining evaluation?Journal of Clinical Pathology, 2004
- Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor ReceptorJournal of Clinical Oncology, 2004
- The EGFR as a target for anticancer therapy—focus on cetuximabEuropean Journal of Cancer, 2001
- Autocrine growth factors and cancerNature, 1985